Pharmicell Co., Ltd.
Clinical trials sponsored by Pharmicell Co., Ltd., explained in plain language.
-
Stem cell treatment for Post-Surgery ED: safety check underway
Disease control Recruiting nowThis study is a safety follow-up for 32 men who previously received an experimental stem cell treatment (Cellgram-ED) for erectile dysfunction after prostate removal due to cancer. Researchers are monitoring tumor markers, serious side effects, and any cancer recurrence over time…
Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Heart attack stem cell therapy under Long-Term safety watch
Disease control Recruiting nowThis study follows 100 people who received Hearticellgram-AMI, a stem cell treatment for acute heart attacks, to see if any serious side effects appear years later. Researchers are watching for death, new cancers, or immune reactions. The goal is to confirm the treatment's long-t…
Phase: NA • Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC